Thioredoxin-interacting protein (Txnip) has been recently described as a possible link between cellular redox state and metabolism; Txnip binds thioredoxin and inhibits its disulfide reductase activity in vitro, while a naturally occurring strain of Txnip-deficient mice has hyperlipidemia, hypoglycemia, and ketosis exacerbated by fasting. We generated Txnip-null mice to investigate the role of Txnip in glucose homeostasis. Txnip-null mice were hypoglycemic, hypoinsulinemic, and had blunted glucose production following a glucagon challenge, consistent with a central liver glucose-handling defect. Glucose release from isolated Txnip-null hepatocytes was 2-fold lower than wild-type hepatocytes, whereas â€-hydroxybutyrate release was increased 2-fold, supporting an intrinsic defect in hepatocyte glucose metabolism. While hepatocyte-specific gene deletion of Txnip did not alter glucose clearance compared with littermate controls, Txnip expression in the liver was required for maintaining normal fasting glycemia and glucose production. In addition, hepatic overexpression of a Txnip transgene in wildtype mice resulted in elevated serum glucose levels and decreased ketone levels. Liver homogenates from Txnip-null mice had no significant differences in the glutathione oxidation state or in the amount of available thioredoxin. However, overexpression of wild-type Txnip in Txnip-null hepatocytes rescued cellular glucose production, whereas overexpression of a C247S mutant Txnip, which does not bind thioredoxin, had no effect. These data demonstrate that Txnip is required for normal glucose homeostasis in the liver. While available thioredoxin is not changed in Txnip-null mice, the effects of Txnip on glucose homeostasis are abolished by a single cysteine mutation that inhibits binding to thioredoxin.Tight regulation of glucose homeostasis is fundamental to all higher life forms, and dysregulated glucose metabolism is a significant medical problem (1, 2). The liver has a major role in determining glucose levels through its control of both hepatic glucose uptake and glucose release. During fasting states the liver is particularly important, as it is the primary organ for maintaining blood glucose levels by up-regulating gluconeogenesis and glycogenolysis to increase glucose release (3, 4). These processes are coordinated by hormonal control, primarily through the reciprocal actions of glucagon and insulin, as well as through glucocorticoid and adipokine cues (5, 6). Downstream effectors of hormonal inputs include transcription factors and coactivators that act as master regulators of metabolic transcriptional programs, such as PGC1âŁ, 3 CREB, TORC2, and Foxo1 (7-10). Other mechanisms governing hepatic carbohydrate metabolism include changes in substrate availability (11), changes in mitochondrial respiration (12, 13), and altered cellular redox state (14, 15).The thiol-disulfide redox state of the cell is emerging as an important regulator of diverse processes, including metabolism (16 -19). A key regulator is thioredoxin, a u...